生物标志物 生物标志物
Anna Orduña Dolado1, Andrea Benedet2, Alexa Pichet Binette3
1Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
NULISA平台为阿尔茨海默病 (AD),同核蛋白和血管病理识别了不同的蛋白质. 这些蛋白质在疾病进展过程中表现出动态变化,突出了区分共同病理的蛋白质组学.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 修订后的阿尔茨海默氏症协会标准强调了与粉样蛋白-β (Aβ) 和蛋白一起出现的同病症,如同核蛋白病变和血管问题.
- 区分这些共同病理对于准确诊断和了解疾病机制至关重要.
研究的目的:
- 利用自动化的NULISA平台来区分阿尔茨海默病 (AD),α-synuclein和血管病理.
- 在脑脊液 (CSF) 和与这些病理相关的血中识别差异丰富的蛋白质 (DAP).
主要方法:
- 通过NULISA中枢神经系统和炎症面板分析了BioFINDER-1和BioFINDER-2队伍的749名参与者.
- 使用线性模型调整年龄,性别和蛋白质水平,同时考虑所有病理的鉴定DAP.
- 评估了DAP与连续病理测量 (Aβ-PET,tau-PET,白质病变,α-synuclein病理) 的关联在一个子队列中.
主要成果:
- 确定了84个DAP,主要与AD和血管病理有关,其中一些显示反向关联.
- 发现了特定的蛋白质 (ENO2,GOT1,VSNL1,MDH1,p-tau) 与AD积极相关,与白质病变负相关.
- 在AD假药和白质病变负载上观察到不同的蛋白质轨迹,表明疾病进展过程中的动态变化.
结论:
- NULISA平台成功地确定了AD,同核素和血管病理的不同的DAP,其重叠程度最小.
- 这些DAP在疾病进展和负载上表现出显著的动态变化,表明它们在区分共同病理方面的潜力.
- 蛋白质组学面板显示,它有望提高复杂的神经退行性疾病的诊断和理解.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516